2.30pm – 3.30pm BST, 22 May 2025 ‐ 1 hour
Roundtables
Associate Director, Ventures, Cancer Research Horizons
Phil has a BSc in Cell Biology from the University of Essex, and a PhD in Virology from the University of Cambridge. After a post-doc position at the National Institute for Medical Research (NIMR) in London, Phil spent a number of years managing R&D programmes in the biotech industry.
He moved into technology transfer in 2003 when he joined Cancer Research Horizons (formerly called Cancer Research Technology). Since that time, he has built up extensive experience of managing and commercialising healthcare technologies from academic origins, focusing in recent years on the creation of innovative and transformative oncology ventures, from ideation to launch.
He has served as a Board Director or Observer for a range of start-up companies including Artios Pharma, Monte Rosa Therapeutics, Infinitopes, MyT BIO, Elaitra and Oncodrug.
Investment Director, Longwall Ventures
Rebecca began venture investing in 2006 while at Oxford Capital, where she took responsibility for the Oxford Gateway Funds’ investments into healthcare and life science companies, and went on to become Director, Healthcare Ventures at Imperial Innovations (now part of IP Group). Her earlier career was as a marketing consultant to pharmaceutical and life science technology companies. Rebecca has a PhD in Genetics from Nottingham University and an MBA from Oxford University. She joined Longwall Ventures after a couple of years sabbatical break spent exploring South America in a VW camper van and focuses predominantly on medical technology opportunities.Managing Partner, LQD
Santiago directs the day-to-day activities at LQD, drawing on his experience as an executive, angel investor and founder, as well as a product and strategy consultant. He works with entrepreneurs to understand their ambitions and provides support across the various stages of venture-building.
Prior to founding LQD, Santiago held a range of operational and consultative roles in companies including IBM, IDEO, Method Design, AVG Technologies. He is happiest at the intersection of technology, business, and design, and is passionate about deep tech’s promise to improve the world.
Santiago has held or holds various NED and board seats at early-stage companies in the UK and in charities based in his native country, Ecuador.